Automating NGS library preparation to meet the scale of CRISPR research

Editing Process, automation, NGS | December 4, 2024 | By Joseph Walsh, Grant Mishler, Leah Chong, Lilian Chang
Automating NGS library preparation to meet the scale of CRISPR research
Share

Scaling Cell Culture with Argo Automation: How EditCo Delivers High-Throughput Precision

Read the Blog
Scaling Cell Culture with Argo Automation: How EditCo Delivers High-Throughput Precision
Editing Process

Scaling Cell Culture with Argo Automation: How EditCo Delivers High-Throughput Precision

Delivering high-quality, precisely edited cells requires more than just cutting-edge CRISPR technology—it begins with a strong foundation in cell culture. Meet Argo: The Backbone of EditCo’s Automated Cell Culture Named after the legendary ship that carried Jason and the Argonauts, Argo represents our modern-day vessel for scientific exploration. Housed in a sterile enclosure, Argo is the backbone of our cell culture operations, built for high-throughput expansion, refeeding, and imaging of both immortalized and induced pluripotent stem (iPS) cells . Figure 1. Photo of the Argo workcell.

Read More
CRISPR Confidence: The Power of Controls in Genome Editing
CRISPR Screening

CRISPR Confidence: The Power of Controls in Genome Editing

Key Takeaways CRISPR controls are essential for optimizing editing efficiency, validating phenotypes, and improving experimental reproducibility. Positive, negative, AAVS1, and lethal controls each serve distinct purposes throughout CRISPR workflows. CRISPR controls are widely used in functional genomics, pooled and arrayed screening, stem cell engineering, and drug discovery. EditCo provides validated CRISPR control reagents compatible with immortalized, primary, and iPSC models. Common CRISPR Control Types and Their Applications CRISPR genome editing is transforming biological research, and experimental controls are the backbone of reliable, reproducible results. In this article, we explore the essential role of CRISPR controls and supporting reagents in optimizing editing efficiency, troubleshooting workflows, and ensuring consistency across experiments. Whether you’re editing immortalized cells , iPSCs , or primary cells , CRISPR positive and negative controls are key to unlocking the full potential of your gene editing experiments. Why CRISPR Controls Matter CRISPR controls are not just “nice to have” — they are fundamental to every step of a genome editing experiment: Optimization: Use controls to fine-tune transfection parameters and editing protocols across different cell types and workflows. Controls help establish optimal conditions before investing in gene-specific reagents. Assay Development : Optimize transfection conditions and editing performance before targeting your gene of interest. Screening and Validation : Confirm editing efficiency and distinguish true biological effects from technical artifacts. Troubleshooting : Identify potential problems with delivery, reagent performance, or cell health. Without appropriate controls, even the most promising CRISPR screen can yield ambiguous or misleading results.

Read More
Killer CRISPR Cells: Unlocking the Functionality in Edited CD8+ T Cells
Editing Process

Killer CRISPR Cells: Unlocking the Functionality in Edited CD8+ T Cells

Key Takeaways • CRISPR editing can impair CD8+ T-cell function if editing and recovery conditions are not optimized. • EditCo’s workflow preserves cytotoxic activity after editing. • Edited T cells demonstrated up to 99% killing of CD19+ target cells in a BiTE assay. • Functional validation is just as important as editing efficiency. CRISPR-Cas9 is revolutionizing cell engineering, opening up new research possibilities such as easier disease modeling, clearer functional gene pathway analysis, novel drug target screening, or creating tailored immune cell therapies. However, not all cell lines are easily edited and often cell lines, such as primary immune cells, risk having their downstream functionality affected by the genetic changes or the editing process itself. One major hurdle researchers face when working with CD8+ T cells (also known as Cytotoxic T Cells or CTL) is maintaining their cytotoxicity after editing. The EditCo Bio R&D team recognized this challenge when developing our T cell editing process and was determined to succeed where others often falter.

Read More